Used in pharmaceutical research as an intermediate in the synthesis of bioactive compounds targeting neurological disorders. Shows potential in the development of agents affecting central nervous system receptors due to its structural similarity to known neuroactive molecules. Employed in studies exploring treatments for addiction, depression, and Parkinson’s disease. Also utilized in the preparation of isoquinoline-based derivatives for structure-activity relationship (SAR) analysis in medicinal chemistry.